发明名称 |
FIBRONECTIN AND FIBRINOGEN BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE |
摘要 |
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease. |
申请公布号 |
AU2002336850(A1) |
申请公布日期 |
2003.06.10 |
申请号 |
AU20020336850 |
申请日期 |
2002.10.31 |
申请人 |
SYN.X PHARMA, INC. |
发明人 |
GEORGE JACKOWSKI;JOHN MARSHALL |
分类号 |
G01N27/62;A61K39/395;A61K45/00;A61P3/04;A61P3/06;A61P3/08;A61P3/10;A61P7/02;A61P9/04;A61P9/10;A61P9/12;A61P13/02;A61P13/12;A61P19/06;A61P43/00;C07K7/08;C07K14/78;C07K16/36;C12P21/08;C12Q1/02;G01N33/483;G01N33/53;G01N33/577;G01N33/68;(IPC1-7):C07K14/00 |
主分类号 |
G01N27/62 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|